Eden Research (LON:EDEN) Trading Up 26.5% – Should You Buy?

Eden Research plc (LON:EDEN) was up 26.5% during mid-day trading on Wednesday . The company traded as high as GBX 3.48 ($0.05) and last traded at GBX 3.48 ($0.05). Approximately 778,726 shares were traded during trading, an increase of 16% from the average daily volume of 670,749 shares. The stock had previously closed at GBX 2.75 ($0.04).

Eden Research Trading Up 2.6%

The business has a 50 day simple moving average of GBX 2.82 and a 200-day simple moving average of GBX 3.44. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.42 and a current ratio of 3.80. The stock has a market capitalization of £21.33 million, a P/E ratio of -14.01 and a beta of 0.92.

Eden Research (LON:EDEN) last issued its quarterly earnings results on Tuesday, May 6th. The company reported GBX (0.36) ($0.00) earnings per share (EPS) for the quarter. Eden Research had a negative net margin of 38.70% and a negative return on equity of 11.63%. On average, analysts predict that Eden Research plc will post -66.0000038 EPS for the current year.

Insider Transactions at Eden Research

In related news, insider Alexander John Abrey acquired 167,947 shares of Eden Research stock in a transaction dated Tuesday, March 4th. The stock was acquired at an average cost of GBX 3 ($0.04) per share, with a total value of £5,038.41 ($6,705.36). Also, insider Sean M. Smith bought 426,986 shares of the firm’s stock in a transaction dated Tuesday, April 1st. The stock was acquired at an average cost of GBX 234 ($3.11) per share, with a total value of £999,147.24 ($1,329,714.19). Corporate insiders own 14.02% of the company’s stock.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.